BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27134252)

  • 1. The Frequency of Scleroderma Renal Crisis over Time: A Metaanalysis.
    Turk M; Pope JE
    J Rheumatol; 2016 Jul; 43(7):1350-5. PubMed ID: 27134252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
    Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
    Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
    J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma renal crisis.
    Bose N; Chiesa-Vottero A; Chatterjee S
    Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
    Wangkaew S; Lertthanaphok S; Puntana S; Noppakun K
    Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
    Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.
    Marí-Alfonso B; Simeón-Aznar CP; Guillén-Del Castillo A; Rubio-Rivas M; Trapiella-Martínez L; Todolí-Parra JA; Rodríguez Carballeira M; Marín-Ballvé A; Iniesta-Arandia N; Colunga-Argüelles D; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas Hitos JA; Chamorro AJ; Madroñero-Vuelta AB; Perales-Fraile I; Pla-Salas X; Fernández-De-La-Puebla RA; Fonollosa-Pla V; Tolosa-Vilella C; ;
    Semin Arthritis Rheum; 2018 Jun; 47(6):849-857. PubMed ID: 29246416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.
    Muangchan C; ; Baron M; Pope J
    J Rheumatol; 2013 Sep; 40(9):1545-56. PubMed ID: 23858045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
    Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
    Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma hypertensive renal crisis among systemic sclerosis patients: A national emergency department database study.
    Uddin M; Mir T; Surapaneni S; Mehar A; Dar T; Changal K; Ullah W; Lohia P; Bhat Z; Sheikh M; Burket M
    Am J Emerg Med; 2022 Mar; 53():228-235. PubMed ID: 35078051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.